This study evaluates the effects of an investigational medication on patients who experience nausea and vomiting during chemotherapy.
The study evaluates how well the investigational medication works in improving the quality of life for patients. It looks at factors like nausea, vomiting, sleep quality, pain, and overall well-being.
- Who can participate: Adults aged 18 to 80 years with metastatic pancreatic adenocarcinoma and adequate organ function can participate, with a performance status of 0-2.
- Study details: Participants will take either the investigational medication or a placebo along with chemotherapy.